OTC Cough/Cold Resumes Line Extension, Launch Activity
This article was originally published in The Tan Sheet
Firms are returning to line extension activity for iconic brands such Alka-Seltzer, Robitussin, Triaminic and Vicks, some with OTC monograph ingredients added to provide new indications. Market researchers project category growth through 2014 and discuss factors affecting cough/cold product sales.
You may also be interested in...
Three of seven businesses warned since February 2022 about noncompliance with FDA drug reporting requirements have been marketers of OTC cough/cold/congestion formulations made with dextromethorphan or guaifenesin.
FDA, FTC shoot down GermBullet claims; Emu products cited for disease claims; Novartis cough/cold recall in Canada; Super Power spiked with sildenafil; more Regulatory News In Brief.
CEO Manfred Scheske believes cocoa flavoring gives Dr. Cocoa an edge in the children’s OTC space, where competitors already offer flavors in many products. Experts says flavors make taking a medicine more appealing to children, but some question whether flavors should be used.